COVID-19 vaccine innovation could dramatically speed up worldwide production
AMAG signs European partner as they hunt cash to get their lead drug through the clinic
New CCC19 data offer insights on COVID treatments for people with cancer
Neutralizing antibodies isolated from COVID-19 patients may suppress virus
GSK Buys 10% Stake In Germany’s CureVac To Develop mRNA Vaccines
Mandatory COVID-19 vaccinations? Here's what states and employers can legally require
Biogen to study Spinraza in combination with $2 million Novartis drug
Moderna’s $37B market cap is too high, despite COVID-19 vaccine; analyst
Pfizer-BioNTech potential Covid-19 vaccine shows promise in additional data
Why vaccines are less effective in the elderly, and what it means for COVID-19
Inozyme plans $75m IPO as it heads for clinic with rare bone diseases drug
UC Davis Health tests monoclonal antibodies as potential COVID-19 treatment
Wave of coronavirus study results raise hope for vaccines
Oxford immunologist on coronavirus vaccine: our early results look highly promising
New diagnostic test for heart failure patients could also help COVID-19 patients
First human trial of Oxford Covid-19 vaccine shows promise
First data on Oxford/AstraZeneca, CanSino coronavirus vaccines ‘promising’
Immunotherapy safe for patients with COVID-19, cancer
BeiGene, Assembly Bio Ink $540M China HBV Deal; Shares Surge In Pre-Market
UK announces COVID-19 vaccine deals with BioNTech/Pfizer and Valneva
Alnylam’s Anant Murthy on making it as a US biotech in Europe
Hydroxychloroquine ineffective against mild Covid-19, U.S. study shows
Breakthrough blood test detects positive COVID-19 result in 20 minutes
Call for COVID-19 ‘challenge trial’ ahead of AstraZeneca vaccine readout
Study: Five-year review of all alzheimer’s drugs in development shows reason for optimism
Dynavax Teams Up With Mt Sinai On Universal Flu Vaccine
CZI awards $1.3 million to support the global rare disease community
Will telehealth services become the norm following COVID-19 pandemic?
Exclusive: J&J says in talks with Japan, Gates Foundation to lock in deals on COVID-19 vaccine
Bad News For Moderna: More Evidence Shows COVID-19 Antibodies Disappear Not Long After Infection